Table 3.
Associations with week 26 CIN2 +
| Characteristic | Univariate Analysis: OR (95% CI) of CIN2 + | p-value | Multivariable Analysis: OR (95% CI) of CIN2 + | p-value |
|---|---|---|---|---|
| ART Use at screening | 0.7 (0.2, 2.8) | 0.638 | ||
| CD4 < 500 cells/mm3 | 1.3 (0.4, 4.5) | 0.696 | ||
| HIV RNA ≥ LLQ | 2.1 (0.7, 6.7) | 0.201 | ||
| Age < 20 years at first vaginal sex | 6.9 (0.8, 57.9) | 0.074 | ||
| With > 1 lifetime vaginal sex partner | 0.3 (0.1, 1.0) | 0.046 | 0.3 (0.1, 0.8) | 0.023 |
| With ≥ 2 years (104 weeks) of ART at entry | 0.8 (0.3, 2.6) | 0.724 | ||
| Week 26 Abbott HPV 16 | 3.0 (0.5, 17.3) | 0.219 | ||
| Week 26 Abbott HPV 18 | N/A* | N/A* | ||
| Week 26 Abbott Other hr-HPV | 3.1 (0.8, 12.0) | 0.109 | ||
| Week 26 Abbott hr-HPV | 5.8 (1.1, 30.6) | 0.036 | 3.5 (1.0, 12.0) | 0.044 |
| Week 26 Less Often Condom Use during vaginal sex | 0.9 (0.3, 3.0) | 0.890 | ||
| Week 26 Not using condom during last vaginal sex | 1.6 (0.4, 6.3) | 0.515 | ||
| Week 26 With > 1 vaginal sex partner in last 6 months | N/A* | N/A* |
*No OR (95% CI) and p-value provided due to convergence issues